Finanzen von 89Bio Inc (ETNB)ETNB89Bio Inc

Evaluating the bottom line, 89Bio Inc maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -69.30%, provide a clear picture of how effectively ETNB converts its operational activities into shareholder value.

In the context of the broader market, ETNB competes directly with industry leaders such as SPRY and BHVN. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, ETNB's gross margin of N/A stands against SPRY's 61.83% and BHVN's N/A. Such benchmarking helps identify whether 89Bio Inc is trading at a premium or discount relative to its financial performance.